Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Intersect ENT, Inc. Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization January 25, 2022 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT Reports Third Quarter 2021 Financial Results November 02, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT Reports Second Quarter 2021 Financial Results August 06, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT to Report Second Quarter 2021 Financial Results on August 6 July 23, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan July 22, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery May 20, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT Reports First Quarter 2021 Financial Results May 10, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT to Participate at Upcoming Investor Conferences May 07, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT Announces Appointment of New Vice President of Sales May 04, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT Announces Date Change for First Quarter 2021 Financial Results Announcement April 29, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation April 29, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Intersect ENT to Report First Quarter 2021 Financial Results April 20, 2021 From Intersect ENT, Inc. Via Business Wire Tickers XENT Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.